Back to Research Hub
Axsome Therapeutics, Inc.
AXSM
$245.64+10.50 (+4.47%)
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
StreetsValue research for Axsome Therapeutics, Inc. (AXSM)
Members get the full report for Axsome Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.